Holen Sie sich die Stockscreener-App
1.4701
3.28%
-0.0499
Schlusskurs vom Vortag:
$1.52
Offen:
$1.52
24-Stunden-Volumen:
357.51K
Relative Volume:
0.18
Marktkapitalisierung:
$74.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-67.68M
KGV:
-0.8856
EPS:
-1.66
Netto-Cashflow:
$-54.24M
1W Leistung:
-11.44%
1M Leistung:
-5.76%
6M Leistung:
-38.49%
1J Leistung:
-78.63%
1-Tages-Spanne:
$1.45
$1.55
1-Wochen-Bereich:
$1.45
$1.7394
52-Wochen-Spanne:
$0.9857
$6.74
Cabaletta Bio Inc Stock (CABA) Company Profile
Firmenname
Cabaletta Bio Inc
Sektor
Branche
Telefon
(267) 759-3100
Adresse
2929 ARCH STREET, PHILADELPHIA, PA
Vergleichen Sie CABA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CABA
Cabaletta Bio Inc
|
1.4701 | 140.31M | 0 | -67.68M | -54.24M | -1.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.93 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.23 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
394.93 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
675.71 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.43 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-20 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-19 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-10-10 | Eingeleitet | UBS | Buy |
| 2024-02-05 | Eingeleitet | Jefferies | Buy |
| 2023-11-29 | Eingeleitet | William Blair | Outperform |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-19 | Eingeleitet | Stifel | Buy |
| 2023-09-05 | Eingeleitet | Citigroup | Buy |
| 2023-07-18 | Eingeleitet | Guggenheim | Buy |
| 2023-01-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-06-30 | Eingeleitet | Mizuho | Buy |
| 2021-01-08 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-10-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-19 | Eingeleitet | Cowen | Outperform |
| 2019-11-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-11-19 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Cabaletta Bio Inc Aktie (CABA) Neueste Nachrichten
What is the risk reward ratio of investing in Cabaletta Bio Inc. stockReal Time Review For Beginners - jammulinksnews.com
Is it the right time to buy Cabaletta Bio Inc. stockStock Strategy Tracker For Every Investor - jammulinksnews.com
Cabaletta Bio Inc. Company’s Quarterly Earnings Growth: What the Numbers SayDaily Chart Pattern Stock Forecast Shows Bullish Setup - metal.it
Why Cabaletta Bio Inc. stock attracts strong analyst attentionExit Ready Momentum Stock Watchlist Expanded - metal.it
Is Cabaletta Bio Inc. a growth stock or a value stockRetirement Planning Watchlist For Fast Growth - jammulinksnews.com
What catalysts could drive Cabaletta Bio Inc. stock higher in 2025Breakout Stocks Opportunities That Work - jammulinksnews.com
How volatile is Cabaletta Bio Inc. stock compared to the marketChart Pattern Updates With High Returns - jammulinksnews.com
What makes Cabaletta Bio Inc. stock price move sharplyMarket-beating performance - jammulinksnews.com
What’s the recovery path for long term holders of Cabaletta Bio Inc.Free Low Drawdown Real Time Trading Tips - Newser
Applying big data sentiment scoring on Cabaletta Bio Inc.High Return Strategy with Low Risk - Newser
Key resistance and support levels for Cabaletta Bio Inc.Market Correction Proof Stock Screening Analysis - Newser
How to track smart money flows in Cabaletta Bio Inc. Profit Target Planning with Exit Confidence - Newser
How strong is Cabaletta Bio Inc. company’s balance sheetMaximize your portfolio’s earning power - jammulinksnews.com
Should I hold or sell Cabaletta Bio Inc. stock in 2025Build a winning investment strategy - jammulinksnews.com
When is Cabaletta Bio Inc. stock expected to show significant growthInvest in stocks with strong fundamentals - jammulinksnews.com
How does Cabaletta Bio Inc. generate profit in a changing economyOutperformance with explosive growth - jammulinksnews.com
Cabaletta Bio Inc. Company Revenue and Profit Trends: A Deep Dive200 Percent Watchlist - metal.it
What is Cabaletta Bio Inc. company’s growth strategyAchieve unparalleled market performance - jammulinksnews.com
Will Cabaletta Bio Inc. Stock Benefit from AI and Green Energy TrendsIntraday Trade Ideas - metal.it
Is Cabaletta Bio Inc. Stock Overbought or Oversold RSI Indicator Analysis - Newser
How Resilient Is Occidental Petroleum Corporation Stock During Economic Downturns3x Return Stock Radar - Newser
What drives Cabaletta Bio Inc. stock priceRapid market gains - PrintWeekIndia
Why Cabaletta Bio Inc. stock is on top investor watchlistsSkyrocketing returns - jammulinksnews.com
What analysts say about Cabaletta Bio Inc. stockHigh-yield capital appreciation - Autocar Professional
Cabaletta Bio Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - jammulinksnews.com
Is Cabaletta Bio Inc. a good long term investmentUnprecedented profits - jammulinksnews.com
Will Cabaletta Bio Inc. stock benefit from interest rate changesPredictable High Return Trades - Newser
Cabaletta Bio’s RESET-SLE Study: A Promising Step in Lupus Treatment - TipRanks
Finanzdaten der Cabaletta Bio Inc-Aktie (CABA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):